Aha1/Hsp90-IN-2
Aha1/Hsp90-IN-2 is a selective inhibitor of the Hsp90/Aha1 interaction, with its IC50 being 1.46 μM. Aha1/Hsp90-IN-2 inhibits the activation of Hsp90 ATPase activity mediated by Aha1 by specifically blocking the binding of Hsp90 to Aha1, thereby reducing tau protein aggregation. Aha1/Hsp90-IN-2 can be used for the study of neurodegenerative diseases, such as Alzheimer's disease[1].
Product Specifications
UNSPSC
12352005
Target
HSP; Tau Protein
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
O=S(C1=CC(C2=CC=CC(OC)=C2)=C(OC)C=C1)(NC3=CC=C(C(F)(F)F)C=C3)=O
Molecular Formula
C21H18F3NO4S
Molecular Weight
437.43
References & Citations
[1]Kevin C, et al. Optimization of Hsp90/Aha1 Small-Molecule Disruptors Via the Evaluation of Amide Bioisosteres. 2025 Nov 7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Fibronectin (TV-1), CF594 conjugate, 0.1mg/mL
Human IgG Immunoglobulin (IG266), CF488A conjugate, 0.1mg/mL
CD106 / VCAM1 (1.4C3), CF488A conjugate, 0.1mg/mL
Mucin 5AC (MUC5AC) (45M1), CF740 conjugate, 0.1mg/mL
